On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will roll out a new, temporary program covering GLP-1s for obesity for people with Medicare. The program, known as the Medicare GLP-1 Bridge, provides coverage of GLP-1s used for weight reduction and weight management to eligible beneficiaries enrolled in Medicare Part D, although the program will operate outside of the Part D benefit and payment system.